Eton Pharmaceuticals (ETON) EPS (Weighted Average and Diluted) (2020 - 2025)
Eton Pharmaceuticals' (ETON) quarterly EPS (Weighted Average and Diluted) came in at -$0.07 in Q3 2025, down 450.0% year-on-year from $0.02 in Q3 2024, and down 450.0% quarter-over-quarter from $0.02 in Q3 2024.
Eton Pharmaceuticals (ETON) EPS (Weighted Average and Diluted) (2020 - 2025) Analysis & Trends
Eton Pharmaceuticals has disclosed EPS (Weighted Average and Diluted) across 6 years of filings, most recently posting -$0.07 for Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 0.31 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 5.82 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.91 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -0.40 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.80 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -0.40 |
| 10 | Eton Pharmaceuticals | 806.97 Mn | 781.03 Mn | 13.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -0.07 |
| Sep 30, 2024 | 0.02 |
| Jun 30, 2024 | -0.12 |
| Mar 31, 2024 | -0.03 |
| Sep 30, 2023 | -0.02 |
| Jun 30, 2023 | 0.18 |
| Mar 31, 2023 | -0.10 |
| Sep 30, 2022 | -0.12 |
| Jun 30, 2022 | -0.06 |
| Mar 31, 2022 | -0.21 |
| Sep 30, 2021 | -0.24 |
| Jun 30, 2021 | -0.08 |
| Mar 31, 2021 | 0.19 |
| Jun 30, 2020 | -0.23 |
| Mar 31, 2020 | -0.50 |